Jianhua Zhang1,2,3,4, Kai Yue1,2,3, Yansheng Wu1,2,3

  • 1Department of Head and Neck Oncology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.

PloS one
|June 10, 2025
PubMed
概括

这项研究确定了关键的溶酶体相关基因 (LAG),以改善 papillary thyroid carcinoma (PTC) 的风险分层. 一个新的LAG评分系统有助于预测患者的预后和潜在的治疗目标.